Monopar Therapeutics Inc.

Q3 2024 13F Holders

Symbol
MNPR
CUSIP
61023L207
Type
Equity
Class
COM NEW
Num filings
7
Total reported value, excl. options
$106 k
Manager Report Date Value ($000) Shares Option Type